Project Grant R34DA063987
Award Date 5/1/26
Completion Date 3/31/29
Dollars Obligated $252K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Bronx, NY 10461, USA
Similar Awards
- Federal Grant Award Summary Albert Einstein College of Medicine received a $199,584 Project Grant award on March 15, 2026, from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year mentored research and career development initiative led by Dr. Michele Buonora. The award funds a hybrid effectiveness-implementation study examining patient-controlled analgesia (PCA) for treating acute pain in hospitalized individuals with...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $647,142 to The University of Kentucky Research Foundation under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct controlled research examining the impact of cannabis on opioid self-administration in individuals with opioid use disorder (OUD). The project, initiated February 15, 2026 and concluding November 30, 2030, addresses a critical public health gap by providing the first controlled data on...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University's Health Sciences Division a $1.49M Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) beginning September 15, 2025, with completion targeted for May 31, 2030. This research initiative will conduct a longitudinal investigation of Veterans Health Administration (VHA) patient data to examine the relationship between cannabis use disorder (CUD) and opioid-related health outcomes....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai $507,000 on September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct translational research on the epigenetic mechanisms underlying cannabis use disorder (CUD). The project, titled "Multiscale Insights into the Epigenetic Basis of THC Consumption," will operate through May 31, 2030, and focuses on developing preclinical models...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1.2M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 15, 2025, with completion scheduled for March 31, 2030. This award supports research investigating transposable element (TE) expression and gene regulation in the context of HIV-1, antiretroviral therapy (ART), and cannabinoid exposure at the single-cell level. The...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $465,250 Project Grant effective September 1, 2025, through August 31, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279). This award funds a double-blind, placebo-controlled human laboratory study investigating pregnenolone as a potential treatment for cannabis intoxication. The research will assess whether pregnenolone, which functions as a signaling-specific...
- Federal Project Grant Award Summary Albert Einstein College of Medicine has received a $756,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded March 15, 2026, with completion scheduled for February 28, 2029. This award funds formative research and pilot testing of implementation strategies designed to improve Pre-Exposure Prophylaxis (PrEP) engagement among hospitalized people who use substances (PWUS). The...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $1,517,762 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective July 1, 2025, through March 31, 2030. The award supports research leveraging integrative computational modeling and artificial intelligence-based tools to develop safer opioid therapeutics. The research addresses the critical public health challenge of opioid misuse and overdose...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $450,175 under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Research Foundation For Mental Hygiene, Inc., through its New York State Psychiatric Institute division, to conduct a clinical research study investigating the efficacy of sphenopalatine ganglion (SPG) nerve blocks as an adjunctive treatment for opioid use disorder (OUD). The award, effective May 15, 2026, through April 30, 2028, funds...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Wisconsin–Milwaukee a Project Grant totaling $1,189,634 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a longitudinal research study examining the relationship between circulating endocannabinoid (ECB) system biomarkers and neurocognitive development in adolescent youth. The project, spanning from July 1, 2025, through March 31, 2030, will utilize blood serum samples...